> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Cerovene Generic Daraprim Approved
- URL: https://www.fdaweb.com/cerovene-generic-daraprim-approved/
- Published: 2020-02-28T12:00:00.000Z
- Updated: 2026-09-14T16:04:56.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5146209

FDA has approved a Cerovene ANDA for the first generic copy of Vyera Pharmaceuticals’ Daraprim (pyrimethamine) tablets for treating toxoplasmosis (an infection caused by the parasite *Toxoplasma gondii*) when used with a sulfonamide. Severe toxoplasmosis is more likely in pregnant women and individuals who have weak immune systems, such as those with HIV or AIDS, those taking certain types of chemotherapy and those who have recently received an organ transplant, an [agency release](http://s2027422842.t.en25.com/e/es?s=2027422842&e=307191&elqTrackId=376c7bc788024cd5a73d955f2e3dcbdc&elq=55199b8b5b9e43ccb237ef3aee638f1b&elqaid=11432&elqat=1&ref=fdaweb.com) says. The most common side effects for pyrimethamine include hypersensitivity reactions that can occasionally be severe, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, erythema multiforme, anaphylaxis shock and hyperphenylalaninemia (elevated concentration of the amino acid phenylalanine in the blood), particularly when pyrimethamine is administered at the same time as a sulfonamide.